Despite our failure to find significant differences based on data in the TIMER2 database, we found that SMARCA1 expression was much higher in tumor tissues than in normal tissues in GBM and LGG based on the GEPIA2 data (combined TCGA and GTEx database) (P < 0.001). This evidence concerns the gene SMARCA1 and neoplasm.